Patents by Inventor Marc Flajolet

Marc Flajolet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the treatment of A-? related disorders and compositions therefor
    Patent number: 9532980
    Abstract: The invention provides methods for treating A? peptide related disorders such as Alzheimer's disease comprising administering a therapeutically effective amount of a CK1 modulator to a patient in need thereof.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: January 3, 2017
    Assignee: The Rockefeller University
    Inventors: Marc Flajolet, Paul Greengard
  • METHODS FOR THE TREATMENT OF A-BETA RELATED DISORDERS AND COMPOSITIONS THEREFOR
    Publication number: 20100143361
    Abstract: The invention provides methods for treating A? peptide related disorders such as Alzheimer's disease comprising administering a therapeutically effective amount of a CK1 modulator to a patient in need thereof.
    Type: Application
    Filed: October 24, 2007
    Publication date: June 10, 2010
    Applicant: Rockefeller University
    Inventors: Marc Flajolet, Paul Greengard
  • Exhaustive analysis of viral protein interactions by two-hybrid screens and selection of correctly folded viral interacting polypeptides
    Publication number: 20040229213
    Abstract: This invention relates to the detection and analysis of viral protein-protein interactions using a two-hybrid system. This invention allows the definition and use of minimal peptides involved in these protein-protein interactions. In particular, this invention relates to the use of a two-hybrid assay to screen for molecules that interact with hepatitis C virus proteins.
    Type: Application
    Filed: December 3, 2003
    Publication date: November 18, 2004
    Applicants: INSTITUT PASTEUR, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Pierre Legrain, Marc Flajolet, Giuseppe Rotondo, Catherine Transy, Genevieve Inchauspe
  • Exhaustive analysis of viral protein interactions by two-hybrid screens and selection of correctly folded viral interacting polypeptides
    Publication number: 20020102534
    Abstract: This invention relates to the detection and analysis of viral protein-protein interactions using a two-hybrid system. This invention allows the definition and use of minimal peptides involved in these protein-protein interactions. In particular, this invention relates to the use of a two-hybrid assay to screen for molecules that interact with hepatitis C virus proteins.
    Type: Application
    Filed: September 26, 2001
    Publication date: August 1, 2002
    Applicant: Institut Pasteur and Institut National de la Sante et de la Recherche Medicale
    Inventors: Pierre LeGrain, Marc Flajolet, Giuseppe Rotondo, Catherine Transy, Genevieve Inshauspe